Marie B. Enemark

Palle Juul Jensens Boulevard 82
Aarhus N, 8200, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Co-shared genomic alterations within tumors from patients with both myeloproliferative neoplasms and lymphoma.

Co-shared genomic alterations within tumors from patients with both myeloproliferative neoplasms and lymphoma.

Journal: Haematologica

Published: June 21, 2023

Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma.

Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma.

Journal: Blood cancer journal

Published: April 28, 2023

Proteomic Profiling Identifies Specific Leukemic Stem Cell-Associated Protein Expression Patterns in Pediatric AML Patients.

Proteomic Profiling Identifies Specific Leukemic Stem Cell-Associated Protein Expression Patterns in Pediatric AML Patients.

Journal: Cancers

Published: May 23, 2022

Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients.

Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients.

Journal: Cancers

Published: January 21, 2022

CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus.

CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus.

Journal: Leukemia & lymphoma

Published: January 12, 2022

Proteomic Profiling Differentiates Lymphoma Patients with and without Concurrent Myeloproliferative Neoplasia.

Proteomic Profiling Differentiates Lymphoma Patients with and without Concurrent Myeloproliferative Neoplasia.

Journal: Cancers

Published: October 05, 2021

Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorder.

Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorder.

Journal: Acta oncologica (Stockholm, Sweden)

Published: September 03, 2021

Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation.

Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation.

Journal: Case reports in hematology

Published: November 23, 2020

Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies.

Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies.

Journal: European journal of haematology

Published: November 22, 2020

Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study.

Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study.

Journal: Blood

Published: May 28, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026